These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38416775)

  • 21. Drug effects on metabolic profiles of Schistosoma mansoni adult male parasites detected by 1H-NMR spectroscopy.
    Guidi A; Petrella G; Fustaino V; Saccoccia F; Lentini S; Gimmelli R; Di Pietro G; Bresciani A; Cicero DO; Ruberti G
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008767. PubMed ID: 33044962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
    Coeli R; Baba EH; Araujo N; Coelho PM; Oliveira G
    PLoS Negl Trop Dis; 2013; 7(12):e2596. PubMed ID: 24367712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance of Schistosoma mansoni to praziquantel: is there a problem?
    Doenhoff MJ; Kusel JR; Coles GC; Cioli D
    Trans R Soc Trop Med Hyg; 2002; 96(5):465-9. PubMed ID: 12474468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a human-serum-based in vitro growth method for drug screening on juvenile development stages of Schistosoma mansoni.
    Buchter V; Schneeberger PHH; Keiser J
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009313. PubMed ID: 33784302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
    Sabra AA; Salem MB; William S; Hammam OA; El-Lakkany NM
    Exp Parasitol; 2022 Aug; 239():108293. PubMed ID: 35667394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
    Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
    Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docking-Based Virtual Screening Enables Prioritizing Protein Kinase Inhibitors With
    Moreira BP; Batista ICA; Tavares NC; Armstrong T; Gava SG; Torres GP; Mourão MM; Falcone FH
    Front Cell Infect Microbiol; 2022; 12():913301. PubMed ID: 35865824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni-induced liver fibrosis in mice.
    Elsakkar MG; Eissa MM; Hewedy WA; Nassra RM; Elatrebi SF
    Life Sci; 2016 Oct; 162():95-101. PubMed ID: 27528511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.
    Pinto-Almeida A; Mendes T; Armada A; Belo S; Carrilho E; Viveiros M; Afonso A
    PLoS One; 2015; 10(10):e0140147. PubMed ID: 26445012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
    Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
    Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
    Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
    J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCR synthesis of praziquantel derivatives.
    Liu H; William S; Herdtweck E; Botros S; Dömling A
    Chem Biol Drug Des; 2012 Apr; 79(4):470-7. PubMed ID: 22151001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antischistosomal properties of aurone derivatives against juvenile and adult worms of Schistosoma mansoni.
    Pereira VRD; da Silveira LS; Mengarda AC; Alves Júnior IJ; da Silva OOZ; Miguel FB; Silva MP; Almeida ADC; Torres DDS; Pinto PF; Coimbra ES; de Moraes J; Couri MRC; da Silva Filho AA
    Acta Trop; 2021 Jan; 213():105741. PubMed ID: 33159900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
    Ellakany AR; Elgendy DI; Alshenawy HA; Abdel Ghaffar AE
    Parasitol Res; 2019 Dec; 118(12):3399-3408. PubMed ID: 31655904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition.
    French MD; Churcher TS; Basáñez MG; Norton AJ; Lwambo NJ; Webster JP
    Acta Trop; 2013 Nov; 128(2):196-205. PubMed ID: 22440199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection.
    Obonyo CO; Were VO; Wamae P; Muok EMO
    Trials; 2023 Nov; 24(1):763. PubMed ID: 38012787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Praziquantel: An update on the mechanism of its action against schistosomiasis and new therapeutic perspectives.
    Nogueira RA; Lira MGS; Licá ICL; Frazão GCCG; Dos Santos VAF; Filho ACCM; Rodrigues JGM; Miranda GS; Carvalho RC; Nascimento FRF
    Mol Biochem Parasitol; 2022 Nov; 252():111531. PubMed ID: 36375598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
    Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
    Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
    Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
    Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.